Letters to the Editor
Unmasking and exacerbation of myasthenia gravis by ophthalmic solutions: Betoxolol, tobramycin, and dexamethasone. A case report
First published: 25 April 2007
No abstract is available for this article.
References
- 1
Argov, Z.,
Wirguin, I:
Drugs and the neuromuscular junction: pharmacotherapy of transmission disorders and drug-induced myasthenic syndromes, in
RP Lisak,
(ed):
Handbook of myasthenia gravis and myasthenic syndromes.
New York, Marcel Dekker,
1994,
pp 295–319.
- 2
Coppeto, JR:
Timolol-associated myasthenia gravis.
Am JOphthalmol
1984;
98:
244–245.
- 3
De Rosayro, M,
Healy, TEJ:
Tobramycin and neuromuscular transmission in the rat isolated phrenic nerve-diaphragm preparation.
Br J Anaesth
1978;
50:
251–254.
- 4
Khella, SL;
Management of criticlly ill patients with myasthenia gravis, the Guillian-Barre syndrome and the inflammatory my opathies,
in
BF Mandell,(ed):
Management of critically ill patents with Immunological and Rheumatic Disese.
New York, Marcel Dekker
1994,
pp 475–504.
- 5
Shaivitz, SA:
Timolol and myasthenia gravis.
JAMA
1979;
242: 1611–1612.
- 6
Verkijk, A
Worsening of myasthenia gravis with timolol maleate eye drops.
Ann izieurol
1985;
17:
211–212.
- 7
Waterman, PM,
Smith, RB:
Tobramycin-curare interaction.
Anesth Analg
1977;
56:
587–588.
